These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

734 related articles for article (PubMed ID: 30565368)

  • 1. Clinical relevance of amnestic versus non-amnestic mild cognitive impairment subtyping in Parkinson's disease.
    Chung SJ; Park YH; Yun HJ; Kwon H; Yoo HS; Sohn YH; Lee JM; Lee PH
    Eur J Neurol; 2019 May; 26(5):766-773. PubMed ID: 30565368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of independence in instrumental activities of daily living: Amnestic versus nonamnestic MCI.
    Putcha D; Tremont G
    J Clin Exp Neuropsychol; 2016 Nov; 38(9):991-1004. PubMed ID: 27240585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical characteristics and cognitive features of mild cognitive impairment in Parkinson's disease and the analysis of relevant factors.
    Nie K; Gao Y; Mei M; Guo M; Huang Z; Wang L; Zhao J; Zhang Y; Wang L
    J Clin Neurosci; 2019 May; 63():142-148. PubMed ID: 30732989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conscious attention defect and inhibitory control deficit in Parkinson's Disease-Mild Cognitive Impairment: A comparison study with Amnestic Mild Cognitive Impairment multiple domain.
    Cammisuli DM; Sportiello MT
    Psychiatr Danub; 2017 Dec; 29(4):437-445. PubMed ID: 29197200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural Brain Volume Covariance Associated with Gait Speed in Patients with Amnestic and Non-Amnestic Mild Cognitive Impairment: A Double Dissociation.
    Allali G; Montembeault M; Saj A; Wong CH; Cooper-Brown LA; Bherer L; Beauchet O
    J Alzheimers Dis; 2019; 71(s1):S29-S39. PubMed ID: 31127784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shared and specific dynamics of brain activity and connectivity in amnestic and nonamnestic mild cognitive impairment.
    Zhong X; Chen B; Hou L; Wang Q; Liu M; Yang M; Zhang M; Zhou H; Wu Z; Zhang S; Lin G; Ning Y
    CNS Neurosci Ther; 2022 Dec; 28(12):2053-2065. PubMed ID: 35975454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frontal-executive dysfunction affects dementia conversion in patients with amnestic mild cognitive impairment.
    Jung YH; Park S; Jang H; Cho SH; Kim SJ; Kim JP; Kim ST; Na DL; Seo SW; Kim HJ
    Sci Rep; 2020 Jan; 10(1):772. PubMed ID: 31964931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mild cognitive impairment reverters have a favorable cognitive prognosis and cortical integrity in Parkinson's disease.
    Chung SJ; Park YH; Yoo HS; Lee YH; Ye BS; Sohn YH; Lee JM; Lee PH
    Neurobiol Aging; 2019 Jun; 78():168-177. PubMed ID: 30947112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain metabolism and cerebrospinal fluid biomarkers profile of non-amnestic mild cognitive impairment in comparison to amnestic mild cognitive impairment and normal older subjects.
    Coutinho AM; Porto FH; Duran FL; Prando S; Ono CR; Feitosa EA; Spíndola L; de Oliveira MO; do Vale PH; Gomes HR; Nitrini R; Brucki SM; Buchpiguel CA
    Alzheimers Res Ther; 2015 Sep; 7(1):58. PubMed ID: 26373380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autonomic function in amnestic and non-amnestic mild cognitive impairment: spectral heart rate variability analysis provides evidence for a brain-heart axis.
    Nicolini P; Mari D; Abbate C; Inglese S; Bertagnoli L; Tomasini E; Rossi PD; Lombardi F
    Sci Rep; 2020 Jul; 10(1):11661. PubMed ID: 32669640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
    Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
    Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Olfactory identification in amnestic and non-amnestic mild cognitive impairment and its neuropsychological correlates.
    Vyhnalek M; Magerova H; Andel R; Nikolai T; Kadlecova A; Laczo J; Hort J
    J Neurol Sci; 2015 Feb; 349(1-2):179-84. PubMed ID: 25614440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropathological comparisons of amnestic and nonamnestic mild cognitive impairment.
    Dugger BN; Davis K; Malek-Ahmadi M; Hentz JG; Sandhu S; Beach TG; Adler CH; Caselli RJ; Johnson TA; Serrano GE; Shill HA; Belden C; Driver-Dunckley E; Caviness JN; Sue LI; Jacobson S; Powell J; Sabbagh MN
    BMC Neurol; 2015 Aug; 15():146. PubMed ID: 26289075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subtypes of mild cognitive impairment in patients with Parkinson's disease: evidence from the LANDSCAPE study.
    Kalbe E; Rehberg SP; Heber I; Kronenbuerger M; Schulz JB; Storch A; Linse K; Schneider C; Gräber S; Liepelt-Scarfone I; Berg D; Dams J; Balzer-Geldsetzer M; Hilker R; Oberschmidt C; Witt K; Schmidt N; Mollenhauer B; Trenkwalder C; Spottke A; Roeske S; Wittchen HU; Riedel O; Dodel R
    J Neurol Neurosurg Psychiatry; 2016 Oct; 87(10):1099-105. PubMed ID: 27401782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gray matter atrophy patterns of mild cognitive impairment subtypes.
    Zhang H; Sachdev PS; Wen W; Kochan NA; Crawford JD; Brodaty H; Slavin MJ; Reppermund S; Draper B; Zhu W; Kang K; Trollor JN
    J Neurol Sci; 2012 Apr; 315(1-2):26-32. PubMed ID: 22280946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Theory of mind in mild cognitive impairment and Parkinson's disease: The role of memory impairment.
    Maggi G; Giacobbe C; Vitale C; Amboni M; Obeso I; Santangelo G
    Cogn Affect Behav Neurosci; 2024 Feb; 24(1):156-170. PubMed ID: 38049608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neuropsychiatric profile of Parkinson's disease subjects with and without mild cognitive impairment.
    Monastero R; Di Fiore P; Ventimiglia GD; Camarda R; Camarda C
    J Neural Transm (Vienna); 2013 Apr; 120(4):607-11. PubMed ID: 23400362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parkinson's disease with mild cognitive impairment: severe cortical thinning antedates dementia.
    Gasca-Salas C; García-Lorenzo D; Garcia-Garcia D; Clavero P; Obeso JA; Lehericy S; Rodríguez-Oroz MC
    Brain Imaging Behav; 2019 Feb; 13(1):180-188. PubMed ID: 28710667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frontal atrophy as a marker for dementia conversion in Parkinson's disease with mild cognitive impairment.
    Chung SJ; Yoo HS; Lee YH; Lee HS; Ye BS; Sohn YH; Kwon H; Lee PH
    Hum Brain Mapp; 2019 Sep; 40(13):3784-3794. PubMed ID: 31090134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploratory analysis of neuropsychological and neuroanatomical correlates of progressive mild cognitive impairment in Parkinson's disease.
    Lee JE; Cho KH; Song SK; Kim HJ; Lee HS; Sohn YH; Lee PH
    J Neurol Neurosurg Psychiatry; 2014 Jan; 85(1):7-16. PubMed ID: 23828835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.